These findings suggest that tumor cells with high HEC1 expression exhibit heterogeneity in cell cycle‐metabolism interactions and can modulate the tumor immunological microenvironment through the interaction, mainly with CAFs and macrophage. The gene discussed is NDC80; the disease is neoplasm.